Interesting preprint on the antibody response after ChAdOx1-nCOV (Covishield) and BBV-152 (Covaxin) among Health Care Workers. (N=552 Covishield =456; Covaxin=96)
Both vaccines elicited👍immune response after 2nd dose. Seropositivity Covishield >Covaxin medrxiv.org/content/10.110…
A number of factors include Age, Sex. Comorbidity including T2DM and Hypertension influence the antibody titres (Day 21-36 after 2nd dose)
More reasons why we should be eagerly looking forward to the Phase 3 data for Covaxin
Another preprint now online on Immunogenicity of the ChAdOx1 nCoV-19 and the BBV152 Vaccines in Patients with Autoimmune Rheumatic Diseases. papers.ssrn.com/sol3/papers.cf…
The data also has healthy controls in comparison where the Ab titres have been examined. While small numbers cannot really ascertain the differences, the Median & IQR values show the same trend in Covaxin vs Covishield
A new preprint comparing the neutralization against B.1.351 and B.1.617.2 compared to B.1 with sera of COVID-19 recovered cases and vaccinees of BBV152 biorxiv.org/content/10.110…
B.1.618 - a new lineage of SARS-CoV-2 predominnatly found in India and characterized by a distinct set of genetic variants including E484K , a major immune escape variant.
Initial sequences in the B.1.618 lineage were found in West Bengal, India.
Members of this lineage is also found in other parts of the world, cov-lineages.org/lineages/linea… but do not have the full complement of variants as found in India
This lineage is characterized by a 6 nt deletion (H146del &Y145del) , apart from E484K and D614G in spike protein
Other variants are in the ORF1ab, ORF3a, ORF7a, ORF7b and N genes
This lineage is defined by 15 genetic variants including 6 Spike protein variants.
Two variants of these 6 (E484Q and L452R) are involved in immune escape as well as increased infectivity. More about these variants and immune escape can be found at ESC clingen.igib.res.in/esc
This lineage is also now found in a number of countries including UK, USA, Australia, Singapore and Germany
#Genome sequencing of the #SARSCoV2 isolates from both the episodes suggest distinctly different virus , confirming reinfection.
Since the individuals were #asymptomatic during both episodes, and identified on regular #surveillance suggest asymptomatic #reinfections could be an under-reported entity. 2/2
High throughput approaches for detection and genetic epidemiology of SARS-CoV-2 holds key as we open up economic hubs & cities. #COVIDseq provides the way forward.
@IGIBSocial in #India is one of the initial centres to evaluate this approach globally and suggesting high sensitivity for detection, along with the opportunity to do genetic epidemiology to understand dynamics.